Why Neubase Therapeutics (NBSE) Shares Are Nosediving
Why Neubase Therapeutics (NBSE) Shares Are Nosediving
Neubase Therapeutics Inc (NASDAQ:NBSE) shares are trading lower by 53% to $0.47 during Tuesday's session after the company on Monday announced it is holding a Special Meeting of Stockholders on May 13, online, to discuss and vote on the proposed liquidation and dissolution of the company, along with an adjournment proposal if necessary.
Neubase Therapeutics Inc（纳斯达克股票代码：NBSE）股价在周二的交易中下跌了53％，至0.47美元，此前该公司周一宣布将于5月13日在网上举行股东特别会议，讨论和表决该公司的清算和解散提案，必要时还将提出休会提案。
The Board of Directors unanimously recommends voting in favor of these proposals, considering them beneficial for NeuBase and its stockholders. The meeting will be conducted virtually, and stockholders must register by May 12, to attend.
董事会一致建议对这些提案投赞成票，认为这些提案对NeuBase及其股东有利。会议将以虚拟方式进行，股东必须在5月12日之前注册才能参加。
It's emphasized that both attending and voting are important, and detailed instructions on how to participate and vote are provided in the accompanying proxy statement. The notice is signed by Todd Branning, Interim Chief Executive Officer and Chief Financial Officer.
有人强调，出席和投票都很重要，随附的委托书中提供了有关如何参与和投票的详细说明。该通知由临时首席执行官兼首席财务官托德·布兰宁签署。
Is NBSE A Good Stock To Buy?
NBSE 是一只值得购买的好股票吗？
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages – like NeuBase Therapeutics's page for example – there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
投资者在决定股票是否值得买入时可以做出一些决定。除了可以在Benzinga的报价页面（例如NeuBase Therapeutics的页面）上找到的估值指标和价格走势外，还有一些因素，例如公司是否每季度支付股息或购买大部分股票。
These are known as capital allocation programs. NeuBase Therapeutics does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's dividend calendar for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
这些被称为资本分配计划。NeuBase Therapeutics不支付股息，但显然有几种方法可以向股东返还价值。您可以随时在Benzinga的股息日历中搜索下一家即将派发股息的公司，并确定持有该公司股份可以获得什么样的收益率。
For example, if you're looking to earn an annualized return of 14.97%, you'll need to buy a share of ARMOUR Residential REIT by the Apr. 12, 2024. Once done, you can expect to receive a nominal payout of $0.24 on Apr. 29, 2024.
例如，如果您希望获得14.97％的年化回报率，则需要在2024年4月12日之前购买ARMOUR住宅房地产投资信托基金的股份。完成后，您预计将在2024年4月29日收到0.24美元的名义补助金。
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on NeuBase Therapeutics will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
回购计划显然是不同的，而且变化很大。公司可以批准回购计划，并在回购获得批准的时间内酌情购买股票。浏览NeuBase Therapeutics的最新消息通常可以得出该公司最近是否批准了回购计划。回购计划通常作为股价的支撑，作为需求的支撑。
According to data from Benzinga Pro, NBSE has a 52-week high of $5.40 and a 52-week low of $0.59.
根据Benzinga Pro的数据，NBSE的52周高点为5.40美元，52周低点为0.59美元。